Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis.

Swanson AF, Ezekowitz RA, Lee A, Kuo CC.

Infect Immun. 1998 Apr;66(4):1607-12.

3.
4.

Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.

Hall JV, Sun J, Slade J, Kintner J, Bambino M, Whittimore J, Schoborg RV.

Front Cell Infect Microbiol. 2014 Nov 6;4:158. doi: 10.3389/fcimb.2014.00158. eCollection 2014.

5.

A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells.

Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11143-8.

6.
7.
8.

Specific antigens of Chlamydia pecorum and their homologues in C psittaci and C trachomatis.

Baghian A, Kousoulas K, Truax R, Storz J.

Am J Vet Res. 1996 Dec;57(12):1720-5.

PMID:
8950425
9.

The molecular biology and diagnostics of Chlamydia trachomatis.

Birkelund S.

Dan Med Bull. 1992 Aug;39(4):304-20.

PMID:
1526183
10.

Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection.

Oberley RE, Goss KL, Ault KA, Crouch EC, Snyder JM.

Mol Hum Reprod. 2004 Dec;10(12):861-70. Epub 2004 Oct 15.

PMID:
15489244
11.
12.

Detection of Chlamydia pneumoniae by polymerase chain reaction.

Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT.

J Clin Microbiol. 1992 Feb;30(2):434-9.

14.

Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species.

Kuo CC, Puolakkainen M, Lin TM, Witte M, Campbell LA.

Microb Pathog. 2002 Jan;32(1):43-8.

PMID:
11782120
15.

Initial characterization of a chlamydial receptor on mammalian cells.

Kaul R, Chong KL, Wenman WM.

FEMS Microbiol Lett. 1989 Jan 1;48(1):65-9.

PMID:
2714632
16.

Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.

Ramsey KH, Cotter TW, Salyer RD, Miranpuri GS, Yanez MA, Poulsen CE, DeWolfe JL, Byrne GI.

Infect Immun. 1999 Jun;67(6):3019-25.

18.

Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.

Deka S, Vanover J, Dessus-Babus S, Whittimore J, Howett MK, Wyrick PB, Schoborg RV.

Cell Microbiol. 2006 Jan;8(1):149-62.

PMID:
16367874
19.

Assessing a potential role of host Pannexin 1 during Chlamydia trachomatis infection.

McKuen MJ, Dahl G, Fields KA.

PLoS One. 2013 May 20;8(5):e63732. doi: 10.1371/journal.pone.0063732. Print 2013.

20.

Supplemental Content

Support Center